Trial Profile
Clinical assessment of possible associations between long-term glucose-lowering effects of liraglutide and basal insulin combination therapy and remaining beta-cell function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2018
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 Jan 2018 Status changed from active, no longer recruiting to completed.
- 28 Jul 2017 New trial record